Quantum Biopharma (QNTM) Other Non-Current Assets (2020 - 2022)

Quantum Biopharma has disclosed Other Non-Current Assets across 3 years of filings, most recently posting $8.8 million for Q1 2022.

• Other Non-Current Assets for Q1 2022 came in at $8.8 million, up 0.64% year-over-year; the trailing twelve-month figure through Mar 2022 was $8.8 million (up 0.64% YoY), and the FY2021 annual result was $8.6 million, changed 0.43% from the prior year.
• Other Non-Current Assets came in at $8.8 million for Q1 2022 at Quantum Biopharma, up from $8.6 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $9.2 million in Q1 2020 to a low of $8.2 million in Q3 2020.
• The 3-year median for Other Non-Current Assets is $8.6 million (2021), against an average of $8.7 million.
• Peak annual rise in Other Non-Current Assets reached 4.59% in 2021, while the deepest fall reached 5.09% in 2021.
• Quantum Biopharma's Other Non-Current Assets stood at $8.6 million in 2020, then gained by 0.43% to $8.6 million in 2021, then increased by 1.46% to $8.8 million in 2022.
• The last three Other Non-Current Assets figures came in at $8.8 million (Q1 2022), $8.6 million (Q4 2021), and $8.6 million (Q3 2021), per Business Quant data.